BMGL

Basel Medical Group Ltd

Contracts

Total Value

Stock Metrics

0.3%

Short % Float

2.1d to cover · Low squeeze

0.1%

Inst % Float

2 holders · 2026-06-30

UBS Group AG

Top Holder

0.0% of float

6.0M sh

Public Float

43/100

Dilution Score

Medium

Verified regulatory filings & proprietary analysis.

Dilution Risk

43/100

MEDIUM

Inst: 0.07% · Top: UBS Group AG

Biotech Analytics

Biotech / Pharma

8.23

Biotech Grade: F

Insider Buying0

Publications100

Dilution Risk43

Clinical Trials0

Short Interest10